Qianyi Lu
Impact in
-
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
-
- HER2/EGFR in Cancer Research
- Cancer-related Molecular Pathways
Papers in
- Oncology 15
- Cancer Immunotherapy and Biomarkers 7
- HER2/EGFR in Cancer Research 5
-
- Breast Cancer Treatment Studies 7
- Cancer-related molecular mechanisms research 3
- Cancer Genomics and Diagnostics 2
- Cancer, Lipids, and Metabolism 2
- Co-authors
- Ruoxi Hong (26 shared papers)Fei Xu (19 shared papers)Shusen Wang (26 shared papers)Qiufan Zheng (20 shared papers)Wen Xia (15 shared papers)Kuikui Jiang (19 shared papers)Yanxia Shi (9 shared papers)Zhongyu Yuan (15 shared papers)
In The Last Decade
Qianyi Lu
40 papers receiving 310 citations
Peers
Comparison fields: 5 of 58
- Cancer Research 80
- Oncology 120
- Pulmonary and Respiratory Medicine 74
- Genetics 19
- Pathology and Forensic Medicine 25
Countries citing papers authored by Qianyi Lu
This map shows the geographic impact of Qianyi Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qianyi Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qianyi Lu more than expected).
Fields of papers citing papers by Qianyi Lu
This network shows the impact of papers produced by Qianyi Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qianyi Lu. The network helps show where Qianyi Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Qianyi Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 48 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 37 | |
| 2 | 2018 | 34 | |
| 3 | 2021 | 24 | |
| 4 | 2019 | 22 | |
| 5 | 2021 | 19 | |
| 6 | 2020 | 17 | |
| 7 | 2020 | 15 | |
| 8 | 2020 | 15 | |
| 9 | 2021 | 13 | |
| 10 | 2021 | 13 | |
| 11 | 2020 | 10 | |
| 12 | 2018 | 9 | |
| 13 | 2023 | 8 | |
| 14 | 2024 | 8 | |
| 15 | 2022 | 8 | |
| 16 | 2023 | 8 | |
| 17 | 2024 | 5 | |
| 18 | 2020 | 4 | |
| 19 | 2021 | 4 | |
| 20 | 2023 | 4 |
About Qianyi Lu
Qianyi Lu is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Epidemiology and Molecular Biology, having authored 48 papers that have together received 313 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (7 papers), Cancer Immunotherapy and Biomarkers (7 papers), HER2/EGFR in Cancer Research (5 papers), Advanced Breast Cancer Therapies (3 papers), Cancer-related molecular mechanisms research (3 papers), Ferroptosis and cancer prognosis (2 papers), Cancer Genomics and Diagnostics (2 papers) and Cancer, Lipids, and Metabolism (2 papers). The work is most often cited by research in Cancer Research (80 citations), Oncology (120 citations), Pulmonary and Respiratory Medicine (74 citations), Genetics (19 citations) and Pathology and Forensic Medicine (25 citations). Qianyi Lu has collaborated with scholars based in China, Ethiopia and Australia. Frequent co-authors include Ruoxi Hong, Fei Xu, Shusen Wang, Qiufan Zheng, Wen Xia, Kuikui Jiang, Yanxia Shi, Zhongyu Yuan, Ge Qin and Liye Wang. Their work appears in journals such as The Oncologist, Frontiers in Oncology, Journal of Affective Disorders, Cancer Communications and Breast Cancer Research and Treatment.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.